AVO — Advanced Oncotherapy Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Advanced Oncotherapy, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.056	1.01	3.24	2.32	4.26
Net Total Accounts Receivable
Net Total Receivables	4.28	1.47	2.22	0.91	0.225
Total Inventory
Prepaid Expenses
Total Current Assets	12.5	13.7	22.2	26.3	30.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.18	4.09	38.5	38.1	41.1
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Total Assets	45.4	59.5	111	122	141
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	16.7	8.95	6.48	19.2	16.1
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	16.7	25.5	67.9	78.2	79.9
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	28.7	34	42.9	44.1	61.4
Total Liabilities & Shareholders' Equity	45.4	59.5	111	122	141
Total Common Shares Outstanding